Skip to main content
Fig. 1 | Orphanet Journal of Rare Diseases

Fig. 1

From: Adverse event rates and economic burden associated with purine nucleoside analogs in patients with hairy cell leukemia: a US population-retrospective claims analysis

Fig. 1

Patient selection criteria. *OI was defined by any of the following conditions: pulmonary tuberculosis, atypical mycobacteria, cryptococcosis, aspergillosis, histoplasmosis, listeriosis, leishmaniasis, Pneumocystis jiroveci pneumonia, keratitis, onychomycosis, peritonitis, fungemia, endophthalmitis, septic/pyogenic arthritis, and osteomyelitis. HCL hairy cell leukemia, OI opportunistic infection

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172